Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: J Allergy Clin Immunol Pract. 2019 Oct 14;8(3):965–970.e4. doi: 10.1016/j.jaip.2019.09.034

Table II.

Portal activity by patient among patients who ever used the portal by intervention group: Portal only (PT) versus Home Visit in addition to portal training (HV + PT).

Home Visit
and Portal
Training
(HV+ PT)
Portal Training
Only


All Patients
N=87 N=83 N=170
Portal use by activity category among
portal users
n (% of portal users)
  Read Message 75(86%) 69(83%) 144(85%)
  Write Secure Message 30(34%) 24(29%) 54(32%)
  Review lab result 76(87%) 63(76%) 139(82%)
  Review appointment date/location 78(90%) 63(76%) 141(83%)
  Schedule appointment 32(37%) 19(23%) 51(30%)
  Review medication list 52(60%) 47(57%) 99(58%)
  Review immunization record 48(55%) 40(48%) 88(48%)
  Request medication renewal 52(60%) 41(49%) 93(55%)
  Review visit information 49(56%) 44(53%) 93(55%)

Note: This table includes only patients who used the patient portal independently of any assistance from the study staff or home visitors. We exclude all portal usage on days during which there was staff contact with the patient. Portal usage was first identified by an episode of use – defined by a login and logoff or a lapse of time between keystroke. Then, we categorized patient portal usage at the patient keystroke level within episode and counted activity type per episode. Finally, we calculated the number of patients who had ever used the Portal for the key activities (See Appendix) for the definition of key activities in any portal usage episode between the time of randomization and the time of the last data collection. See technical appendix (Appendix) for details in methods for Portal data.